PHILLIP WALKER: Open Payments
NPI 1881060754 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,966 in 194 payments from 16 companies in 2025. Trend: 2023 $3,311 · 2024 $2,552 · 2025 $2,966
Food & beverage: $2,966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $399 |
| Otsuka America Pharmaceutical, Inc. | 22 | $391 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $299 |
| Neurocrine BioSciences, Inc. | 17 | $297 |
| Alkermes, Inc. | 12 | $280 |
| Vanda Pharmaceuticals Inc. | 8 | $183 |
| Axsome Therapeutics, Inc. | 13 | $181 |
| Janssen Pharmaceuticals, Inc | 11 | $167 |
| E.R. Squibb & Sons, L.L.C. | 12 | $166 |
| Teva Pharmaceuticals USA, Inc. | 8 | $155 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, FANAPT, Auvelity, ABILIFY MAINTENA, COBENFY.
Industry payments across KY — which companies pay providers there.
